Alnylam Pharmaceuticals and Sanofi’s Strategic Restructuring of RNAi Therapeutics Rare Disease Alliance

Ambrogio Visconti

Goodwin advised Alnylam Pharmaceuticals, Inc. on its strategic restructuring of its RNAi therapeutics alliance with Sanofi to streamline and optimize development and commercialization of certain products…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now